Pegloticase
Horizon Therapeutics
[]
 mirror rct mtx response of pegloticase in resistant gout pts (60% vs pbo 30.8%) tophus resolution wk 52 &gt;24 (cont. benefit ) drug ab with mtx no new irs abst#0001 #acr22 #plenary 
Rheumatology Research Fellow/SpR ?? St James Hospital Dublin